-
Your selected country is
Denmark
- Change country/language
Old Browser
This page has been recently translated and is available in French now.
BD Horizon™ Dri Tumor & Tissue Dissociation Reagent (TTDR)
(RUO)
Regulatory Status Legend
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Description
BD HorizonTM Dri Tumor & Tissue Dissociation Reagent (TTDR) was designed for gentle and effective dissociation of tumors and tissue for single cell studies. BD TTDR is optimized to maximize cell yields, while minimizing cell death and epitope/antigen damage. The reagent is provided as a kit with 15 single-use amber vials. Each vial contains sufficient reagent to dissociate up to 1.0 g of tissue. NOTEt is feasible to dissociate tissue weighing outside this range, however, it should be tested by the user.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not For Use in Diagnostic Procedures.
RUO/GMP—For Research Use Only. Not for use in diagnostic or therapeutic procedures. Although not required, these products are manufactured in accordance with Good Manufacturing Practices.
23-22943-00
Report a Site Issue
This form is intended to help us improve our website experience. For other support, please visit our Contact Us page.